Anthony A.. Florence Jr's Net Worth
$890 Million
Who is Anthony A.. Florence Jr?
Anthony A.. Florence Jr has an estimated net worth of $890 Million. This is based on reported shares across multiple companies, which include Arcellx, Inc., Berkshire Grey, Inc., Oyster Point Pharma, Inc., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Galera Therapeutics, Inc., IMARA Inc., ZeroFox Holdings, Inc., Senti Biosciences, Inc.\, Mersana Therapeutics, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Desktop Metal, Inc., Cascadian Therapeutics, Inc., MULESOFT, INC, Robinhood Markets, Inc., Nkarta, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., AVEO PHARMACEUTICALS, INC., APPIAN CORP, Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Annexon, Inc., SYNLOGIC, INC., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Casper Sleep Inc., Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Care.com Inc, INTERLEUKIN GENETICS INC, and Korro Bio, Inc..
SEC CIK
Anthony A.. Florence Jr's CIK is 0001559827
Past Insider Trading and Trends
2018 was Anthony A.. Florence Jr's most active year for acquiring shares with 50 total transactions. Anthony A.. Florence Jr's most active month to acquire stocks was the month of May. 2021 was Anthony A.. Florence Jr's most active year for disposing of shares, totalling 52 transactions. Anthony A.. Florence Jr's most active month to dispose stocks was the month of December. 2022 saw Anthony A.. Florence Jr paying a total of $378,955,496.36 for 18,601,468 shares, this is the most they've acquired in one year. In 2019 Anthony A.. Florence Jr cashed out on 78,321,254 shares for a total of $169,898,090.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Berkshire Grey, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.18M |
—
|
—
|
0
|
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nightstar Therapeutics plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.66M |
$25.50 | -$169,894,566.00 |
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.79M |
$15.00 |
—
| 4.79M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arcellx, Inc. (ACLX) Snapshot price: $64.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.65% | -2.00M |
$30.74 | $5,501.96 | 4.75M |
Dec 20 - Dec 21
| |||
Form 4
| +4.86% | 312.5K |
$16.00 | $5,000,000.00 | 6.75M |
Jun 21
| |||
Form 4
|
∞
| 6.43M |
$15.00 | $23,749,995.00 | 6.43M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,737.54% | 5.6M |
$16.00 |
—
| 5.93M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |